Tilray Brands Q3 Earnings Analysis: Behind The CEO’s “Robust” Claims

“Tilray Brands is shaping the future of consumer markets with a robust global infrastructure spanning the beverage, cannabis, and wellness industries. We are meeting the needs of today’s consumers while preparing for the demands of tomorrow..”

Okay, easy there Simon. You just posted a net loss of $794 million dollars for the third quarter. The only thing robust about Tilray Brands (TSX: TLRY) is the continued losses in investor portfolios.

It’s almost like every time a CEO goes on a long soliloquy at the onset of an earnings release about how great they are, it means it was a terrible quarter. And in that regard, Irwin Simon over at Tilray again delivered in Q3.

Lets dive in.


Information for this story was found via the sources and companies mentioned. The author has no securities or affiliations related to the organizations discussed. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Silver @ $36 & We’re Still 200M Oz Short | Paul Andre Huet – Americas Gold and Silver

Gold’s Wild Bull Run: Are Markets About to Break? | Mike McGlone

First Majestic Silver: The Santa Elena Mine

Recommended

Canadian Copper Obtains Financing Commitment From Ocean Partners For Caribou Complex Purchase

PTX Metals Hits 49 Metres of 0.35% Copper In Latest W2 Drill Results

Related News

TIlray: Canaccord Resumes Coverage Following Aphria Transaction

Earlier this week, Tilray (NASDAQ: TLRY) finalized their merger with Aphria (NASDAQ: APHA) (TSX: APHA),...

Saturday, May 8, 2021, 04:20:00 PM

Tilray: Cantor Lowers Price Target, Walks Back Coca-Cola Comments

Last week, Cantor Fitzgerald updated their estimates on a bundle of Canadian License Producers. In...

Thursday, September 23, 2021, 03:23:00 PM

Tilray Year End: Production Success Overshadowed By Impairments

Tilray Inc. (NASDAQ: TLRY), is off -50% since having published its year end financials after...

Tuesday, March 10, 2020, 09:19:21 AM

Tilray: Canaccord Cuts Price Target To $9.00

On January 10th, Tilray Inc (TSX: TLRY) reported their fiscal second-quarter financial results, the company...

Tuesday, January 11, 2022, 04:22:00 PM

Tilray Imports Medical Cannabis to USA to Assist Research on Breast Cancer Related Disorder

Tilray Inc (NASDAQ: TLRY) announced this morning that it has successfully imported medical cannabis from...

Thursday, October 24, 2019, 09:15:29 AM